Jubilant Ingrevia Limited (JUBLINGREA)
ISIN: INE0BY001018 Industry: Biotechnology Sector: Healthcare Website
484.65
7.7(1.61%)

Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.

Pricing Updates

TODAY'S HIGH

493.55

TODAY'S LOW

476.95

52 WEEK HIGH

838.75

52 WEEK LOW

401.2

Major Holders

% of Shares Held by
All Insider

57.78%

% of Shares Held by
Institutions

2.52%

% of Float Held by
Institutions

5.97%

Number of Institutions
Holding Shares

4

Company Overview

MARKET CAP

7719.55 Cr.

ETERPRISE VALUE

7776.54 Cr.

NO. OF SHARES

15.92 Cr.

BOOK VALUE

152.89

DIV. YIELD

2.5%

DEBT

237.84 Cr.

GROSS PROFIT

1687 Cr.

CASH

48.53 Cr.

REVENUE

4970.62 Cr.

REVENUE/SHARE

312.578

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020
Investments129.69 Cr.-2.16 Cr.-2.16 Cr.
Change To Liabilities102.83 Cr.78.64 Cr.39.84 Lakhs
Total cashflows from Investing Activities-71.86 Cr.-43.65 Cr.-43.65 Cr.
Net Borrowings-321.30 Cr.-62.93 Cr.-62.93 Cr.
Total Cash from Financing Activities-417.75 Cr.-72.36 Cr.12 Lakhs
Other Liabilities000
Total Assets0012 Lakhs
Net Income476.71 Cr.54.35 Cr.-39.84 Lakhs
Change in Cash-35.73 Cr.73.29 Cr.12 Lakhs
Effect of Exchange Rate1.14 Cr.9.50 Lakhs9.50 Lakhs
Total Cash from Operating Activities452.74 Cr.112.28 Cr.112.28 Cr.
Depreciation123.39 Cr.21.74 Cr.21.74 Cr.
Other Cashflows from Investing Activities26 Cr.-13.99 Cr.-13.99 Cr.
Dividends Paid-45.15 Cr.-45.15 Cr.-45.15 Cr.
Change to Inventory-304.95 Cr.-37.41 Cr.-37.41 Cr.
Change to Account Receivables-99.10 Cr.-40.27 Cr.-40.27 Cr.
Other Cashflows from Financing Activities-33.04 Cr.-9.42 Cr.-9.42 Cr.
Change to Net Income153.86 Cr.34.90 Cr.34.90 Cr.
Capital Expenditures-230.15 Cr.-27.54 Cr.-27.54 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020
Research DevelopmentNoneNoneNone
Effect of Accounting ChargesNoneNoneNone
Income Before Tax708.94 Cr.77.38 Cr.-39.84 Lakhs
Minority InterestNoneNoneNone
Net Income708.44 Cr.98.40 Cr.-39.84 Lakhs
Selling General Administrative327.28 Cr.49.67 Cr.49.67 Cr.
Gross Profit1687 Cr.314.18 Cr.0
Ebit708.44 Cr.98.40 Cr.-39.84 Lakhs
Operating Income708.44 Cr.98.40 Cr.-39.84 Lakhs
Other Operating Expenses527.89 Cr.144.03 Cr.39.84 Lakhs
Interest Expense-30.94 Cr.-6.98 Cr.-6.98 Cr.
Extraordinary ItemsNoneNoneNone
Non RecurringNoneNoneNone
Other ItemsNoneNoneNone
Income Tax Expense232.23 Cr.23.02 Cr.0
Total Revenue4949.36 Cr.684.13 Cr.0
Total Operating Expenses4240.92 Cr.585.73 Cr.39.84 Lakhs
Cost of Revenue3262.36 Cr.369.95 Cr.0
Total Other Income Expense Net50 Lakhs-21.01 Cr.0
Discontinued OperationsNoneNoneNone
Net Income from Continuous Ops.476.71 Cr.54.35 Cr.-39.84 Lakhs
Net Income Applicable to Common Shares476.71 Cr.54.35 Cr.-39.84 Lakhs

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020
Intangible Assets14.22 Cr.13.01 Cr.0
Capital Surplus0571.32 Cr.0
Total Liabilities1364.03 Cr.1455.58 Cr.16.60 Lakhs
Stock Holder Equity2433.12 Cr.1922.93 Cr.-11.60 Lakhs
Minority Interest000
Other Liabilities106.57 Cr.48.83 Cr.0
Total Assets3797.15 Cr.3378.52 Cr.5 Lakhs
Common Stock15.90 Cr.15.92 Cr.5 Lakhs
Retained Earnings01156.08 Cr.-16.60 Lakhs
Other Liabilities204.88 Cr.97.32 Cr.0
Good Will000
Treasury Stock2417.22 Cr.179.60 Cr.0
Other Assets53.89 Cr.34.51 Cr.0
Cash48.53 Cr.73.34 Cr.5 Lakhs
Current Liabilities1052.78 Cr.894.33 Cr.16.60 Lakhs
Long Term Asset Charges14.92 Cr.12.38 Cr.0
Short Long Term Debt129.06 Cr.89.65 Cr.0
Other Stockholder Equity2417.22 Cr.179.60 Cr.0
Property Plant Equipment1958.28 Cr.1857.15 Cr.0
Total Cur. Assets1764.57 Cr.1423.59 Cr.5 Lakhs
Long Term Investments6.19 Cr.50.24 Cr.0
Net Tangible Assets2418.90 Cr.1909.92 Cr.-11.60 Lakhs
Short Term Investments066.94 Cr.0
Net Receivables582.78 Cr.627.18 Cr.0
Long Term Debt99.69 Cr.455.83 Cr.0
Inventory911.16 Cr.609.10 Cr.0
Accounts Payable797.78 Cr.694.06 Cr.16.60 Lakhs

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account